Although the enhanced TGF-β level was observed in both patients and mice with aortic aneurysm, direct evidence shows that blocking TGF-β by neutralizing antibody accelerates the development of aortic pathology in an Ang II– or elastase-induced aortic aneurysm mouse model (14–16). The gene discussed is TGFB1; the disease is aortic aneurysm.